Diebold Nixdorf, Incorporated (DBD) Stock Overview
Explore Diebold Nixdorf, Incorporated’s financial performance, market position, analyst ratings, and future outlook.
Diebold Nixdorf, Incorporated (DBD)
Key Financials
Key Financials
Market Cap
2.1B
P/E Ratio
20.24
EPS (TTM)
$5.61
ROE
0.11%
DBD Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Diebold Nixdorf, Incorporated (NYSE: DBD) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Diebold Nixdorf, Incorporated's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of DBD on the NYSE shows an RSI of 30.93, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $86.89 for the NYSE listing.
Key metrics behind Diebold Nixdorf, Incorporated's NYSE-traded stock include a P/E ratio of 20.24 and a market capitalization of 2.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of DBD on the NYSE.